Wegovy belongs to a class of drugs called GLP-1 receptor agonists, which imitates the natural hormone glucagon-like peptide-1 (GLP-1) to help control appetite, blood sugar, and metabolism
Recent studies show that this class of drugs is effective in lowering risk of cardiovascular disease and improving sleep apnea and might be appropriate to treat fatty liver disease, Alzheimers disease, smoking cessation and substance use disorder
Research indicates that extended administration of GPS at suitable dosages typically does not result in substantial harm to vital organs
Most individuals were non-Hispanic White (72%), followed by non-Hispanic Black (16%) and Mexican American (4.0%)
Think of glutathione as your bodys internal defense system and cleanup crew all rolled into one
Roche (2015): The Delhi High Court invalidated a secondary patent for a lung cancer drug, reinforcing that minor modifications dont warrant extended protection without clear efficacy gains